Park Avenue Securities’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$634K Buy
4,166
+1,868
+81% +$311K ﹤0.01% 1179
2026
Q1
$482K Buy
2,298
+748
+48% +$188K ﹤0.01% 1120
2025
Q4
$441K Buy
+1,550
New +$485K ﹤0.01% 1149
2022
Q2
Sell
-793
Closed -$211K 1165
2022
Q1
$211K Buy
+793
New +$195K ﹤0.01% 1074
2021
Q4
Sell
-727
Closed -$207K 1129
2021
Q3
$207K Buy
+727
New +$207K ﹤0.01% 990
2020
Q4
Sell
-1,192
Closed -$282K 866
2020
Q3
$282K Buy
1,192
+93
+8% +$19.6K 0.01% 593
2020
Q2
$213K Buy
+1,099
New +$210K 0.01% 621

Other funds holding PODD

Park Avenue Securities's PODD Position: Q2 2026 in Review

Park Avenue Securities increased its Insulet (PODD) stake by 81% in Q2 2026, buying an estimated $311K and bringing the position to 4,166 shares worth $634K. The position accounts for ﹤0.01% of the portfolio, ranked #1179.

Park Avenue Securities first reported a position in PODD in Q2 2020 and has held it in 7 quarters since. 727 funds tracked by Wall St. Rank hold PODD as of Q2 2026.

  • Park Avenue Securities held 4,166 shares of Insulet worth $634K as of Q2 2026.
  • Park Avenue Securities bought 1,868 Insulet shares in Q2 2026, an estimated $311K.
  • Insulet made up ﹤0.01% of Park Avenue Securities's portfolio in Q2 2026, its #1179 holding.
  • Park Avenue Securities first reported a position in Insulet in Q2 2020 and has held it in 7 quarters since.
  • 727 funds tracked by Wall St. Rank held Insulet as of Q2 2026.

Based on Park Avenue Securities's 13F filing for Q2 2026, filed 20 Jul 2026.